MANROS THERAPEUTICS FROM SEA TO PHARMACY Trademark

Trademark Overview


On Thursday, October 18, 2018, a trademark application was filed for MANROS THERAPEUTICS FROM SEA TO PHARMACY with the United States Patent and Trademark Office. The USPTO has given the MANROS THERAPEUTICS FROM SEA TO PHARMACY trademark a serial number of 79251980. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2019. This trademark is owned by MANROS THERAPEUTICS. The MANROS THERAPEUTICS FROM SEA TO PHARMACY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease; chemical preparations for medical or pharmaceutical use, namely, for the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease

Scientific research for medical purposes in the fields of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease
manros therapeutics from sea to pharmacy

General Information


Serial Number79251980
Word MarkMANROS THERAPEUTICS FROM SEA TO PHARMACY
Filing DateThursday, October 18, 2018
Status700 - REGISTERED
Status DateTuesday, September 10, 2019
Registration Number5854023
Registration DateTuesday, September 10, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 25, 2019

Trademark Statements


Description of MarkThe mark consists of a design comprised of two adjacent incomplete circles that each feature a wave design at the top. A group of small solid circles appears inside each incomplete circle. Below the design is the wording "MANROS" above the word "THERAPEUTICS" with the wording "FROM SEA TO PHARMACY" appearing below "THERAPEUTICS".
Goods and ServicesPharmaceutical products for the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease; chemical preparations for medical or pharmaceutical use, namely, for the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease
Pseudo MarkMAN ROS THERAPEUTICS FROM SEA TO PHARMACY
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesScientific research for medical purposes in the fields of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 4, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMANROS THERAPEUTICS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameMANROS THERAPEUTICS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameMANROS THERAPEUTICS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Friday, March 8, 2019APPLICATION FILING RECEIPT MAILED
Thursday, February 14, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 4, 2019ASSIGNED TO EXAMINER
Monday, March 11, 2019NON-FINAL ACTION WRITTEN
Tuesday, March 12, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 21, 2019REFUSAL PROCESSED BY MPU
Thursday, March 21, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 5, 2019REFUSAL PROCESSED BY IB
Monday, May 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 20, 2019ASSIGNED TO LIE
Wednesday, June 5, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 12, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 12, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 25, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, January 9, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 31, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, September 10, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, January 9, 2020FINAL DISPOSITION PROCESSED
Friday, June 28, 2019NOTIFICATION PROCESSED BY IB